Evaluation of the Anti-inflammatory, Antimicrobial, Antioxidant, and Cytotoxic Effects of Chitosan Thiocolchicoside-Lauric Acid Nanogel

Free Radical Scavenging, Anti-inflammatory and Antibacterial Activity of Acorus calamus Leaves Extract Against Pseudomonas aeruginosa and Staphylococcus aureus

Background Herbal medicine, or phytotherapy, has been used for centuries in traditional healing practices to harness the therapeutic properties of different plant-derived elements. Acorus calamus, a perennial herbaceous plant, has significant historical importance in traditional medicine, specifically in Ayurveda, where it is referred to as "Vacha." This study investigates the antioxidant, anti-inflammatory, and antimicrobial characteristics of the A. calamus dimethyl sulfoxide (DMSO) extract. The objectives of the research are to provide valuable knowledge about the preparation of A. calamus DMSO extract and to explore its potential anti-inflammatory, antioxidant, and antimicrobial effects. Materials and methods The A. calamus DMSO extract was derived from leaves, and its antioxidant activity was evaluated through the use of the 2,2-diphenyl-1-picryl hydrazyl (DPPH) assay, hydroxyl radical scavenging assay (H2O2 assay), and ferric reducing antioxidant power (FRAP) assay. The anti-inflammatory activity was assessed using the Bovine serum albumin (BSA) denaturation assay, egg albumin (EA) denaturation assay, and membrane stabilization assays. The antimicrobial activity was analyzed using the agar well diffusion technique and the time-kill curve assay. Results In DPPH and H2O2 tests, the DMSO extract of A. calamus showed significant antioxidant activity, near that of standard ascorbic acid. The FRAP assay demonstrated a correlation between the dose and the activity of reducing ferric ions. The A. calamus DMSO extract exhibited significant anti-inflammatory properties in BSA and EA denaturation assays, similar to the standard diclofenac sodium. The anti-inflammatory potential of the A. calamus DMSO extract was further confirmed through the membrane stabilization assay. The DMSO extract of A. calamus exhibited a significant inhibition zone against the pathogens Streptococcus mutans and Pseudomonas aeruginosa during the antimicrobial evaluation, surpassing the efficacy of the standard antibiotic. The time-kill curve assay validated the antibacterial efficacy, which was dependent on the concentration. Conclusion The A. calamus DMSO extract exhibited promising antioxidant, anti-inflammatory, and antimicrobial properties, supporting its traditional use in alternative medicine. The findings suggest its potential as a natural resource of compounds with bioactive properties for use in pharmaceutical and nutraceutical applications.

Anti-inflammatory activity of lauric acid, thiocolchicoside and thiocolchicoside-lauric acid formulation

It is of interest to develop potent and safer anti-inflammatory drugs from plants, as medicinal plants and herbs attained great attention in the medical world due to their multifunctional activities. This article studied the anti-inflammatory effects of lauric acid (LA), thiocolchicoside (TC) and thiocolchicoside-lauric acid (TC-LA) formulation. The anti-inflammatory effects of these compounds were determined by following the methods of inhibition of protein denaturation and proteinase inhibition activity. This was assessed at different concentrations to determine the 50% inhibition concentration (IC50) of the compounds. The result indicated that the activity of LA, TC, TC-LA formulation, and reference drug increased with the increase in the concentration from 10-50 µg/ml, thus proving the activity of LA, TC, and TC-LA formulation against inflammation was in a dose-dependent manner. The percentage of inhibition of protein denaturation was 59.56%, 66.94%, 86.62%, and 60.34% for LA, TC, the combination of TC-LA and standard drug, and the IC50 values were found to be 44.78 µg/mL, 37.65 µg/mL, 27.15 µg/mL and 43.42 µg/mL, respectively. The percentage of proteinase inhibition activity of LA, TC, and a combination of TC-LA and the standard drug was 66.65%, 77.49%, 94.07%, and 69.83%, and IC50 of LA, TC, a combination of TC-LA and standard drug were35.5 µg/mL, 32.12 µg/mL, 24.35 µg/mL and 37.80 µg/mL, respectively. We found out that lauric acid, thiocolchicoside, and thiocolchicoside-lauric acid formulation exhibited significant anti-inflammatory activity.